The Chicago Entrepreneur

: Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio

Amgen Inc. is acquiring Dublin-based Horizon Therapeutics in a roughly $28 billion deal that is the biggest in the healthcare sector in 2022.

Previous post : U.S. oil futures settle 3% higher on supply worries
Next post Elon Musk is no longer the richest person in the world